Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$1.18
$1.87
$0.39
$18.00
$5.59M3.523,627 shs125 shs
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
$0.33
+6.4%
$0.35
$0.17
$0.50
$92.84M0.813,279 shs53,200 shs
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$0.08
+1.3%
$0.49
$0.05
$23.40
$407K1.31.36 million shs23,084 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.68
+1.2%
$17.66
$14.51
$22.99
$65.57M0.67,892 shs6,361 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%-0.59%-39.18%-69.74%-60.67%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
+7.48%+3.57%-2.72%-11.69%+51.45%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
+3.90%+14.29%-81.47%-91.95%-99.34%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.22%-1.70%+7.20%-14.22%+15.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
1.38 of 5 stars
3.53.00.00.01.10.00.6
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/A
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
3.00
Buy$28.8835,548.15% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K69.92N/AN/A($2.43) per share-0.49
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
$1.18M78.68N/AN/A($0.04) per share-8.33
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
$320K1.27N/AN/A$1.74 per share0.05
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.42$2.26 per share8.26$8.91 per share2.10

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98MN/A0.00N/A-6,809.45%N/A-386.74%5/20/2024 (Estimated)
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
-$11.60M-$0.04N/AN/A-974.16%N/A-210.60%5/10/2024 (Estimated)
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
-$12.87M-$28.55N/AN/A-4,033.54%N/A-110.70%5/8/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7524.91N/A5.59%8.97%5.40%5/2/2024 (Estimated)

Latest ARTH, PDEX, EDTXF, and MOTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A-$0.02-$0.02-$0.02N/A$0.27 million
3/18/2024Q4 2023
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/A-$4.13-$4.13-$3.78N/A$0.06 million
2/20/2024Q1 2024
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A-$0.57-$0.57-$0.57N/A$0.05 million
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/AN/AN/AN/AN/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.16
0.04
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A
0.40
0.37
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
0.46
1.76
1.69
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
N/A
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
20.06%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%

Insider Ownership

CompanyInsider Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
1.50%
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
1.57%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
84.74 million4.53 millionNot Optionable
Spectral Medical Inc. stock logo
EDTXF
Spectral Medical
29278.64 million274.46 millionNot Optionable
Motus GI Holdings, Inc. stock logo
MOTS
Motus GI
155.03 million4.95 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable

ARTH, PDEX, EDTXF, and MOTS Headlines

SourceHeadline
How to use Samsung Dex for gamingHow to use Samsung Dex for gaming
msn.com - April 26 at 8:09 AM
What is Samsung DeX and how does it work?What is Samsung DeX and how does it work?
msn.com - April 23 at 11:18 AM
Pro-Dex Inc. (co)Pro-Dex Inc. (co)
money.usnews.com - April 19 at 10:51 AM
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Decrease in Short InterestPro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Decrease in Short Interest
marketbeat.com - April 13 at 11:20 AM
Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $17.72Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $17.72
marketbeat.com - April 11 at 3:14 AM
AutoPro X accessory will bring Samsung DeX to your vehicleAutoPro X accessory will bring Samsung DeX to your vehicle
msn.com - April 9 at 10:27 AM
Vicarious Surgical Stock (NYSE:RBOT), Quotes and News SummaryVicarious Surgical Stock (NYSE:RBOT), Quotes and News Summary
benzinga.com - April 2 at 10:06 PM
Monogram Orthopaedics reports FY resultsMonogram Orthopaedics reports FY results
seekingalpha.com - March 15 at 3:03 PM
The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Dont Inspire ConfidenceThe Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence
finance.yahoo.com - February 22 at 2:16 PM
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month ResultsPro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
finance.yahoo.com - February 8 at 7:45 PM
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five yearsPro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five years
finance.yahoo.com - January 26 at 7:04 PM
Is Pro-Dex, Inc.s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?
finance.yahoo.com - December 30 at 4:00 PM
Dex Carvey Dies: Comedian Son Of Dana Carvey Was 32Dex Carvey Dies: Comedian Son Of Dana Carvey Was 32
deadline.com - November 22 at 4:30 AM
PowerDEX Launches: CEX Performance Meets DEX FreedomPowerDEX Launches: CEX Performance Meets DEX Freedom
coinspeaker.com - November 21 at 4:16 PM
Here’s Why You Should Consider Buying Pro-Dex (PDEX) SharesHere’s Why You Should Consider Buying Pro-Dex (PDEX) Shares
finance.yahoo.com - November 14 at 2:04 AM
Pro-Dex Inc PDEXPro-Dex Inc PDEX
morningstar.com - November 10 at 12:39 PM
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsPro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
finance.yahoo.com - November 2 at 6:52 PM
Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000
finance.yahoo.com - November 2 at 6:52 PM
Stock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastStock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
finanznachrichten.de - October 26 at 10:18 AM
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastPro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
finance.yahoo.com - October 26 at 10:18 AM
Pro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year ResultsPro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year Results
finance.yahoo.com - October 15 at 12:00 AM
Pro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year ResultsPro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year Results
finance.yahoo.com - October 13 at 7:19 PM
North American Morning Briefing: S&P 500 Futures -2-North American Morning Briefing: S&P 500 Futures -2-
morningstar.com - October 4 at 8:12 AM
Pro-Dexs (NASDAQ:PDEX) Returns Have Hit A WallPro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall
finance.yahoo.com - August 7 at 7:33 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Arch Therapeutics logo

Arch Therapeutics

OTCMKTS:ARTH
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.
Spectral Medical logo

Spectral Medical

OTCMKTS:EDTXF
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Motus GI logo

Motus GI

NASDAQ:MOTS
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.